CA
NZ
UK
AU
IND
US
…
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company's technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. Its principal asset is a patented orally administered dissolvable strip. The company is based in Tampa, Florida.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
CTT Pharmaceutical Holdings Inc is an OTC Pink-listed company that, per limited public filings, describes itself as a pharmaceutical development entity advancing therapeutic candidates. Long-term growth drivers could include clinical progress, regulatory approvals, commercialization or partnerships, which may create upside if the company secures funding and achieves development milestones.
Key risks are limited disclosure and low liquidity, plus development and regulatory execution risk, potential dilution from financings, and governance and operational uncertainty common to OTC Pink issuers.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -0.16M | -0.21M | -0.04M | -0.05M | -0.13M |
| Net income | -0.16M | -0.21M | -0.04M | -0.05M | -0.13M |
| Selling general administrative | 0.15M | 0.24M | - | - | - |
| Gross profit | -0.01M | -0.01M | -0.01M | -0.01M | - |
| Reconciled depreciation | 0.01M | 0.01M | - | - | - |
| Ebit | -0.13M | -0.25M | -0.04M | -0.05M | -0.13M |
| Ebitda | -0.12M | -0.24M | -0.04M | -0.04M | 0.10M |
| Depreciation and amortization | 0.01M | 0.01M | 0.01M | 0.01M | 0.24M |
| Operating income | -0.13M | -0.25M | -0.04M | -0.11M | -0.15M |
| Other operating expenses | 0.13M | 0.25M | 0.04M | 0.11M | 0.15M |
| Interest expense | 0.00M | 0.00M | 0.00M | 0.00M | - |
| Net interest income | -0.00M | 0.00M | - | - | - |
| Income tax expense | - | - | -0.17M | -0.23M | -0.24M |
| Total revenue | 0.00M | 0.00M | - | - | - |
| Total operating expenses | 0.12M | 0.24M | 0.04M | 0.10M | 0.15M |
| Cost of revenue | 0.01M | 0.01M | 0.01M | 0.01M | - |
| Total other income expense net | -0.03M | 0.04M | -0.00M | 0.06M | 0.02M |
| Net income from continuing ops | -0.16M | -0.25M | - | - | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 0.09M | - | 0.08M | 0.09M | 0.11M |
| Intangible assets | 0.07M | - | 0.08M | - | - |
| Other current assets | - | - | - | - | -0.00M |
| Total liab | 0.03M | - | 0.02M | 0.00M | 0.10M |
| Total stockholder equity | 0.06M | - | 0.06M | 0.09M | 0.01M |
| Other current liab | 0.01M | - | 0.01M | 0.00M | - |
| Common stock | 0.01M | - | 0.39M | 0.30M | 0.33M |
| Capital stock | 0.01M | - | - | - | - |
| Retained earnings | -7.55M | - | -7.15M | -7.10M | -7.14M |
| Cash | 0.02M | - | - | 0.01M | 0.10M |
| Total current liabilities | 0.03M | - | 0.01M | 0.00M | 0.10M |
| Net debt | 0.00M | - | 0.01M | -0.01M | -0.10M |
| Short term debt | 0.02M | - | - | - | - |
| Short long term debt | 0.02M | - | - | - | - |
| Short long term debt total | 0.02M | - | 0.01M | - | - |
| Other stockholder equity | 7.60M | - | 6.82M | 6.89M | 6.81M |
| Total current assets | 0.02M | - | - | 0.01M | 0.11M |
| Net receivables | - | - | - | 0.00M | 0.01M |
| Accounts payable | - | - | - | 0.00M | 0.10M |
| Accumulated other comprehensive income | - | - | 0.00M | 0.00M | 0.00M |
| Non currrent assets other | -0.00M | - | - | - | - |
| Non current assets total | 0.07M | - | 0.08M | 0.09M | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total cashflows from investing activities | -0.00M | - | - | - | - |
| Net borrowings | 0.00M | 0.01M | - | - | - |
| Total cash from financing activities | 0.10M | 0.23M | 0.01M | 0.04M | 0.50M |
| Net income | -0.16M | -0.21M | -0.04M | -0.05M | 0.01M |
| Change in cash | 0.02M | 0.00M | -0.01M | -0.09M | -0.10M |
| Begin period cash flow | 0.00M | 0.00M | 0.01M | 0.10M | 0.20M |
| End period cash flow | 0.02M | 0.00M | 0.00M | 0.01M | 0.10M |
| Total cash from operating activities | -0.08M | -0.23M | -0.02M | -0.14M | -0.60M |
| Issuance of capital stock | 0.10M | 0.22M | - | - | - |
| Depreciation | 0.01M | 0.01M | 0.01M | 0.01M | - |
| Change to account receivables | - | - | 0.00M | 0.01M | -0.00M |
| Sale purchase of stock | - | - | -0.07M | - | - |
| Other cashflows from financing activities | - | 0.19M | -0.01M | - | 0.33M |
| Capital expenditures | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Change in working capital | -0.01M | 0.01M | 0.01M | -0.09M | -0.56M |
| Other non cash items | 0.08M | -0.03M | 0.01M | 0.09M | -0.05M |
| Free cash flow | -0.08M | -0.03M | -0.02M | -0.14M | -0.60M |
Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|
| CTTH CTT Pharmaceutical Holdings Inc |
0.01 11.98% |
0.06 | - | - | 1826.32 | 108.91 | -17.87 |
| MKKGY Merck KGaA ADR |
1.01 3.10% |
33.63 | 21.25 | 14.93 | 3.10 | 2.14 | 12.98 |
| MKGAF MERCK Kommanditgesellschaft auf Aktien |
- -% |
167.06 | 24.86 | 15.11 | 3.13 | 1.98 | 18.89 |
| TAK Takeda Pharmaceutical Co Ltd ADR |
-0.20 1.02% |
19.95 | - | 10.96 | 0.01 | 1.20 | 23.11 |
| TKPHF Takeda Pharmaceutical Co. Ltd. |
-0.60 1.58% |
37.37 | - | 10.66 | 0.01 | 1.16 | 23.11 |
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company's technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. Its principal asset is a patented orally administered dissolvable strip. The company is based in Tampa, Florida.
3853 Northdale Blvd, Tampa, FL, United States, 33624
813-606-0060
1
| Name | Title | Year Born |
|---|---|---|
| Ryan Khouri | Chief Exec. Officer | NA |
| Mr. Marc Lakmaaker | Special Advisor & Sr. VP of Commercial Devel. | NA |
| Ryan Khouri | CEO & Director | NA |
| Mr. Marc Lakmaaker | Special Advisor & Senior VP of Commercial Development | NA |
| Mr. Ryan Khouri | Chief Executive Officer | 1980 |
| Dr. Pankaj Modi M.D., Ph.D. | Founder & Consultant | 1955 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
-0.50%
Communication Services
+0.06%
Consumer Cyclical
+0.89%
Consumer Defensive
-0.16%
Energy
-0.11%
Financial Services
+0.50%
Financials
+0.42%
Healthcare
+0.43%
Industrials
+0.60%
Real Estate
+0.40%
Technology
-0.56%
Utilities
+0.37%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...